Evidence map›Paper›PMID 40140941›Full record

ArticleCancer imaging : the official publication of the International Cancer Imaging Society2025

The value of

Eline C Jager, Adrienne H Brouwers, Madelon J H Metman, Dilay Aykan, Lisa H de Vries, Lutske Lodewijk, Menno R Vriens, Schelto Kruijff, Thera P Links

Abstract read
In one paragraph

Article in Cancer imaging : the official publication of the International Cancer Imaging Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. A prospective, exploratory study ofEuropean journal of nuclear medicine and molecular imaging · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Eline C JagerDepartment of Surgery, Division of Surgical Oncology, University Medical Center Groningen, Groningen, The Netherlands.
Adrienne H BrouwersDepartment of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Madelon J H MetmanDepartment of Surgery, Division of Surgical Oncology, University Medical Center Groningen, Groningen, The Netherlands.
Dilay AykanDepartment of Surgical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.
Lisa H de VriesDepartment of Surgical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.
Lutske LodewijkDepartment of Surgical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.
Menno R VriensDepartment of Surgical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.
Schelto KruijffDepartment of Surgery, Division of Surgical Oncology, University Medical Center Groningen, Groningen, The Netherlands. s.kruijff@umcg.nl.
Thera P LinksDepartment of Internal Medicine, Division of Endocrinology, University Medical Center Groningen, Groningen, The Netherlands. t.p.links@umcg.nl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWhile total thyroidectomy with central neck dissection (CND) is standard for medullary thyroid cancer (MTC), performing a lateral neck dissection (LND) depends on locoregional metastatic spread and is usually decided per individual. This study evaluated the utility of preoperative PET/CT in staging patients at diagnosis and guiding the initial surgical plan, while also exploring the value of neck ultrasound, MRI, and CT.

methodsAll MTC patients from two tertiary hospitals (2000 - 2020) were identified from two retrospective databases. All reports of neck ultrasounds, MRIs, CTs and PET/CTs < 8 months prior to primary surgery or < 4 months after MTC diagnosis were reviewed. The sensitivity and specificity of each imaging modality for locating locoregional lymph node metastases (LNM) was determined.

resultsA total of 175 MTC patients were included (91 females and 57 hereditary MTCs). Median age at presentation was 52 years (IQR 38 - 62). Initial treatment included a total thyroidectomy, CND and LND in 155 (89%), 140 (80%) and 59 (33%) patients. Preoperative imaging of the neck included ultrasound (91, 52%), MRI (33, 19%) and CT (31, 18%). PET/CT imaging was performed in 56 (32%) patients (35

conclusionsPET/CT is a powerful tool to detect locoregional LNM and can particularly help identify cases where LNDs are required, avoiding reoperation later on. For accurate staging of the central neck, PET may be combined with diagnostic CT. Finally, PET/CT's ability to detect distant metastases may support de-escalation of a surgical intervention when cure is unlikely.

Indexed as

Carcinoma, NeuroendocrinePositron Emission Tomography Computed TomographyThyroid NeoplasmsAdultDihydroxyphenylalanineFemaleFluorodeoxyglucose F18HumansLymphatic MetastasisMagnetic Resonance ImagingMaleMiddle AgedNeck DissectionPreoperative CareRadiopharmaceuticalsRetrospective StudiesDihydroxyphenylalanineFluorodeoxyglucose F18fluorodopa F 18RadiopharmaceuticalsDeescalationLymph node dissectionMedullary thyroid cancerPET/CTPreoperative imagingSurgery

Identifiers

PMID40140941
PMCPMC11938770

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.